We are live on ! Find out more
LA

Lynch & Associates Portfolio holdings

AUM $573M
1-Year Est. Return 21.74%
This Fund
S&P 500
This Quarter Est. Return
+7.49%
1 Year Est. Return
+21.74%
3 Year Est. Return
+62.9%
5 Year Est. Return
+80.86%
10 Year Est. Return
+253.69%
AUM
$496M
AUM Growth
+$34M
Cap. Flow
+$7.45M
Cap. Flow %
1.5%
Top 10 Hldgs %
39.39%
Holding
128
New
10
Increased
60
Reduced
39
Closed
3

Top Buys

Rank Stock Value
1
COF icon
Capital One
COF
+$4.12M
2
LLY icon
Eli Lilly
LLY
+$755K
3
CTAS icon
Cintas
CTAS
+$753K
4
AVGO icon
Broadcom
AVGO
+$746K
5
WM icon
Waste Management
WM
+$714K

Top Sells

Rank Stock Value
1
DFS
Discover Financial Services
DFS
+$3.62M
2
WMT icon
Walmart Inc
WMT
+$637K
3
DOW icon
Dow Inc
DOW
+$517K
4
ADBE icon
Adobe
ADBE
+$439K
5
JPM icon
JPMorgan Chase
JPM
+$294K

Sector Composition

Rank Sector Weight
1 Technology 19.19%
2 Healthcare 12.92%
3 Consumer Staples 11.29%
4 Industrials 10.37%
5 Financials 9.55%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
MSFT icon
1
Microsoft
MSFT
$2.93T
$51.7M 10.41%
103,923
-605
-0.6% -$263K
IVV icon
2
iShares Core S&P 500 ETF
IVV
$881B
$21.4M 4.3%
34,406
+493
+1% +$283K
WMT icon
3
Walmart Inc
WMT
$909B
$19.1M 3.86%
195,843
-6,682
-3% -$637K
IJH icon
4
iShares Core S&P Mid-Cap ETF
IJH
$122B
$18.9M 3.8%
304,495
+5,643
+2% +$331K
JPM icon
5
JPMorgan Chase
JPM
$907B
$15.9M 3.21%
54,979
-1,153
-2% -$294K
PG icon
6
Procter & Gamble
PG
$349B
$14M 2.83%
88,128
-337
-0.4% -$55K
IBM icon
7
IBM
IBM
$200B
$13.9M 2.8%
47,149
-111
-0.2% -$28.6K
JNJ icon
8
Johnson & Johnson
JNJ
$609B
$13.8M 2.77%
90,118
+711
+0.8% +$109K
ABBV icon
9
AbbVie
ABBV
$450B
$13.6M 2.74%
73,361
+754
+1% +$140K
XOM icon
10
ExxonMobil
XOM
$611B
$13.2M 2.66%
122,321
+2,290
+2% +$245K
CSCO icon
11
Cisco
CSCO
$441B
$10.4M 2.09%
149,705
+860
+0.6% +$52.9K
EMR icon
12
Emerson Electric
EMR
$78.2B
$10.2M 2.05%
76,233
-417
-0.5% -$47.8K
MCD icon
13
McDonald's
MCD
$190B
$9.75M 1.97%
33,387
+64
+0.2% +$19.7K
AAPL icon
14
Apple
AAPL
$4.9T
$9.64M 1.94%
46,993
+177
+0.4% +$35.7K
ABT icon
15
Abbott
ABT
$175B
$8M 1.61%
58,833
+3,163
+6% +$417K
SPYV icon
16
State Street SPDR Portfolio S&P 500 Value ETF
SPYV
$36B
$7.88M 1.59%
150,508
+2,862
+2% +$143K
ITOT icon
17
iShares Core S&P Total US Stock Market ETF
ITOT
$93.7B
$7.71M 1.55%
57,057
+408
+0.7% +$50.9K
CVX icon
18
Chevron
CVX
$373B
$7.44M 1.5%
51,986
-756
-1% -$107K
LMT icon
19
Lockheed Martin
LMT
$117B
$7.3M 1.47%
15,753
-6
-0% -$2.81K
KO icon
20
Coca-Cola
KO
$351B
$7.11M 1.43%
100,462
+88
+0.1% +$6.27K
SYK icon
21
Stryker
SYK
$123B
$7.07M 1.42%
17,874
-86
-0.5% -$32.2K
MRK icon
22
Merck
MRK
$315B
$7.06M 1.42%
89,173
-1,077
-1% -$85.6K
BAC icon
23
Bank of America
BAC
$430B
$6.85M 1.38%
144,784
+1,345
+0.9% +$56.6K
LLY icon
24
Eli Lilly
LLY
$1.05T
$6.68M 1.35%
8,564
+971
+13% +$755K
HON icon
25
Honeywell
HON
$71.3B
$6.44M 1.3%
29,357
+159
+0.5% +$32.2K

Similar funds

Lynch & Associates's Q2 2025 Portfolio in Review

As of Q2 2025, Lynch & Associates held 128 positions worth $496M, up 7.4% from $462M the previous quarter. Its ten largest holdings account for 39% of the portfolio.

Lynch & Associates's Q2 2025 filing shows 10 new, 60 increased, 39 reduced and 3 closed positions. Its largest new stake was Capital One: 22,067 shares worth $4.69M. The largest sale was Discover Financial Services, an estimated $3.62M.

By sector, the portfolio is most concentrated in Technology at 19% of assets, up from 17% a quarter earlier, followed by Healthcare and Consumer Staples.

  • Lynch & Associates's largest Q2 2025 buy was Capital One: 22,067 shares worth $4.69M.
  • Lynch & Associates added most to Eli Lilly in Q2 2025, an estimated $755K increase.
  • Lynch & Associates's biggest Q2 2025 reduction was Walmart Inc, cutting an estimated $637K.
  • Lynch & Associates fully exited Discover Financial Services in Q2 2025, selling an estimated $3.62M.
  • Lynch & Associates's ten largest holdings make up 39% of its $496M portfolio in Q2 2025.
  • Lynch & Associates opened 10 new positions and closed 3 in Q2 2025.
  • Lynch & Associates's portfolio value rose 7.4% quarter-over-quarter to $496M.

Based on Lynch & Associates's 13F filing for Q2 2025, filed 15 Jul 2025.